Related Experiment Video
Updated: Apr 12, 2026

Saline Lavage for Sampling of the Canine Nasal Immune Microenvironment
Published on: December 27, 2024
Antibiotic prescribing in canine infectious respiratory disease
Alec W Thomas1, Alan D Radford2, Helen E Clough2
1Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, L69 3BX, UK.
Abstract:
Canine infectious respiratory disease (CIRD) is a common infection that is seen in veterinary practice. The condition is generally mild, self-limiting and does not usually require the use of antibiotics in the treatment of the infection. The aims of this study were to analyse risk factors for CIRD in a large sentinel UK pet population and secondly, identify risk factors for antibiotics being prescribed to cases of CIRD. Dogs were included in the study based on a regular expression applied to the Small Animal Veterinary Surveillance Network (SAVSNET) database at the University of Liverpool. A generalized linear mixed modelling approach was used to investigate risk factors to account for clustering of cases within individual practices. In total, 2163 cases of CIRD were included in the study, with CIRD cases being positively associated with male dogs (OR = 1.18, 95% CI: 1.07 - 1.30) and the autumn season (OR = 2.42, 95% CI: 2.12 - 2.77). Beta-lactamase antibiotics were the most frequently prescribed antibiotic in this study. The median age of dogs receiving an antibiotic was 8.4 years old. Being an older dog (Mature OR = 2.31, 95% CI: 1.60 - 3.34, Geriatric OR = 2.73, 95% CI: 1.62 - 4.58) and a male dog (OR = 1.44, 95% CI: 1.13, 1.84) was positively associated with the odds of receiving an antibiotic. This study provides information that can be used to aid antimicrobial stewardship programmes within the veterinary sector.
More Related Videos
09:01The Bovine Lung in Biomedical Research: Visually Guided Bronchoscopy, Intrabronchial Inoculation and In Vivo Sampling Techniques
Published on: July 3, 2014
09:17A Robust Pneumonia Model in Immunocompetent Rodents to Evaluate Antibacterial Efficacy against S. pneumoniae, H. influenzae, K. pneumoniae, P. aeruginosa or A. baumannii
Published on: January 2, 2017
Related Concept Videos
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Clinical Significance of Antibiotic Resistance
Acute Respiratory Failure-V
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Mechanism of Antibiotic Resistance in MRSA